LCTX earnings

Lineage Cell Therapeutics (LCTX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.

LCTX earnings history

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026Nov 12, 2026-0.03-0.03-5.01%$1.43M
Q2 2026Aug 6, 2026-0.03-0.03-5.89%$1.07M
Q1 2026May 12, 2026-0.03––$1.73M
Q4 2025Mar 5, 20260.00––$6.61M
Q3 2025Nov 6, 2025-0.13-0.02-550.00%$3.68M
Q2 2025Aug 12, 2025-0.01-0.0250.00%$2.77M
Q1 2025May 13, 2025-0.02-0.020.00%$1.50M
Q4 2024Mar 10, 2025-0.01-0.0475.00%$2.87M
Q3 2024Nov 14, 2024-0.02––$3.78M
Q2 2024Aug 8, 2024-0.03-0.0540.00%$1.41M
Q1 2024May 9, 2024-0.04-0.04-4.36%$1.44M
Q4 2023Mar 7, 2024-0.03-0.02-29.98%$2.09M
Q3 2023Nov 9, 2023-0.04-0.04-6.67%$1.25M
Q2 2023Aug 10, 2023-0.03-0.02-32.28%$3.23M
Q1 2023May 11, 2023-0.03-0.02-21.75%$2.39M
Q4 2022Mar 9, 2023-0.03-0.03-19.24%$1.92M
Q3 2022Nov 10, 2022-0.04-0.04-14.29%$3.00M

Updated 2026-11-17 17:46 UTC